IS5212A - Bætt aðferð til framleiðslu á pýrazólópýrimidínónafleiðu - Google Patents
Bætt aðferð til framleiðslu á pýrazólópýrimidínónafleiðuInfo
- Publication number
- IS5212A IS5212A IS5212A IS5212A IS5212A IS 5212 A IS5212 A IS 5212A IS 5212 A IS5212 A IS 5212A IS 5212 A IS5212 A IS 5212A IS 5212 A IS5212 A IS 5212A
- Authority
- IS
- Iceland
- Prior art keywords
- preparation
- improved method
- pyrazolopyrimidinone derivative
- pyrazolopyrimidinone
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99116030A EP1077214A1 (en) | 1999-08-16 | 1999-08-16 | An improved process for preparing a pyrazolopyrimidinone derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5212A true IS5212A (is) | 2001-02-17 |
Family
ID=8238778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5212A IS5212A (is) | 1999-08-16 | 1999-10-12 | Bætt aðferð til framleiðslu á pýrazólópýrimidínónafleiðu |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1077214A1 (is) |
| IS (1) | IS5212A (is) |
| PL (1) | PL336031A1 (is) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2310144B1 (es) | 2007-06-15 | 2010-01-12 | Galenicum Health, S.L. | Intermedios para la preparacion de un inhibidor de la fosfodiesterasa tipo 5. |
| MX2010006227A (es) | 2010-06-07 | 2011-12-14 | World Trade Imp Exp Wtie Ag | Nuevos derivados 1,4-diazepanos, inhibidores de pde-5. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5250534A (en) * | 1990-06-20 | 1993-10-05 | Pfizer Inc. | Pyrazolopyrimidinone antianginal agents |
| GB9013750D0 (en) * | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
-
1999
- 1999-08-16 EP EP99116030A patent/EP1077214A1/en not_active Withdrawn
- 1999-10-12 IS IS5212A patent/IS5212A/is unknown
- 1999-10-15 PL PL33603199A patent/PL336031A1/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL336031A1 (en) | 2001-02-26 |
| EP1077214A1 (en) | 2001-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS2223B (is) | Aðferð til framleiðslu á 5-sýanóþalíði | |
| CY2007029I1 (el) | Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων | |
| IS6091A (is) | Aðferð til framleiðslu á sítalóprami | |
| IS5952A (is) | Aðferð til framleiðslu á 5-sýanóþalíði | |
| IS5862A (is) | Aðferð til framleiðslu á sítalóprami | |
| IS2468B (is) | Aðferðir og milliefni til framleiðslu á efnasamböndum gegn krabbameini | |
| IS5715A (is) | Aðferð til smíði á 4-karboxýamínó-2-setnu-1,2,3,4-tetrahýdrókínólíni | |
| IS5861A (is) | Aðferð til framleiðslu á sítalóprami | |
| IS2711B3 (is) | Aðferð til framleiðslu á amín platínu komplexum | |
| EE200200183A (et) | Meetod polüisobuteenfenooli sisaldavate Mannichi aduktide saamiseks | |
| ID24790A (id) | Proses untuk memfraksionasi dibutena | |
| ID25682A (id) | Metode untuk melelehkan kaca | |
| IS6487A (is) | Aðferð til framleiðslu á Sítalóprami | |
| ID30091A (id) | Metode untuk menyiapkan l-fenilefrina hidroklorida | |
| IS5600A (is) | Aðferð til framleiðslu á vernduðu 4-amínómetýl-pýrrólidín-3-óni. | |
| IS7153A (is) | Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu | |
| NO20024058D0 (no) | Fremgangsmåte for fremstilling av et oksazolyletanolderivat | |
| TR199800403A3 (tr) | a-Bromo-laktam türevlerinin hazirlanmasi için yöntem. | |
| IS2260B (is) | Aðferð til framleiðslu á sítalóprami | |
| EE200200014A (et) | Dibensotiasepiiniderivaatide valmistamismeetod | |
| DK1088817T3 (da) | Fremgangsmåde til fremstilling af 3-acyl-indoler | |
| IS5212A (is) | Bætt aðferð til framleiðslu á pýrazólópýrimidínónafleiðu | |
| NO20012811D0 (no) | Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat | |
| NO20020328D0 (no) | Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol | |
| NO20020327D0 (no) | Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol |